GSK Eases IP Rights For Poorest Countries, Considers Patent Pooling For Cancer 31/03/2016 by Catherine Saez, Intellectual Property Watch 2 Comments In light of the United Nations Secretary General’s High-Level Panel on Access to Medicines initiative, the GlaxoSmithKline company today announced steps to further help bring innovative medicines to poor countries.
African Tech Start-Ups Face Many Challenges 21/03/2016 by Munyaradzi Makoni for Intellectual Property Watch 1 Comment DAKAR, Senegal – Rachel Sibande won accolades when she started Malawi’s first ever technology start-up mHub in 2013.
High-Level UN Initiative On Global Public Health Gap Holds Landmark Hearing 11/03/2016 by Catherine Saez and William New, Intellectual Property Watch 4 Comments An initiative of the United Nations secretary general yesterday gathered what could be described as an assembly of many of the world’s best thinkers and practitioners on public health and intellectual property rights. Industry, activists, academics, international organisations, and possibly some governments poured out their views for nearly seven hours – at times coming to tears and tension – shepherded by an astute moderator, as they responded to the call to take a longstanding debate on medicines access and high prices to a breakthrough.
East Africa Pharma Summit Examines Linkages Between Domestic Policies, Industry, Trade And Health 29/02/2016 by Fredrick Nzwili for Intellectual Property Watch Leave a Comment NAIROBI, Kenya — As the budding East African pharmaceutical industry shows clear gains , experts at a pharmaceutical summit in Kenya underlined the sector as key to tackling challenges related to access to essential medicines in the region.
Genetics Disclosure Requirement In IP Applications Necessary To Comply With Obligations, Speakers Say 19/02/2016 by Catherine Saez, Intellectual Property Watch 4 Comments As World Intellectual Property Organization members struggled this week to find consensus on the wording of a potential treaty protecting genetic resources from misappropriation, a side event explored the role of WIPO and the intellectual property system in preventing such misappropriation.
Vision, Urgency Of UN High-Level Panel On Access To Medicines Begins To Take Shape 05/02/2016 by William New, Intellectual Property Watch 4 Comments NEW YORK — It came as a surprise to some when the United Nations Secretary General’s office announced in November the setting up of a high level panel to urgently address access to medicines and other health technologies. After all, UN agencies in Geneva, most notably the World Health Organization, have been working on these issues for years. Yesterday at the UN in New York, an event was held to explain some of the vision and urgency behind the setting up of the panel, which includes an expert committee of representatives of some 10 international organisations and others. It also includes an open online call for contributed ideas until 18 February, and two public hearings.
WHO Preps For 2018 UN Review Of Cardiovascular Diseases, Cancers, Respiratory Diseases, Diabetes 03/02/2016 by Jahan Harry Taubman-Rezakhanlou for Intellectual Property Watch Leave a Comment World Health Organization Director-General Margaret Chan submitted a report to last week’s Executive Board meeting detailing progress made in establishing a framework for the implementation of a global action plan for prevention and control of noncommunicable diseases (NCDs – like obesity, cancer, diabetes). The global action plan is to be officially implemented after the United Nations General Assembly comprehensive review of the prevention and control of NCDs in 2018, designed to eventually reduce premature mortality from NCDs by a third in 2030 in accordance with the health-related Sustainable Development Goals.
Special Feature: UN High Level Panel On Access To Medicines – First Reactions, Process Explained 01/02/2016 by Catherine Saez, Intellectual Property Watch 8 Comments A high level panel of experts charged by United Nations secretary general to explore solutions to increase innovation and access to medicines in developing countries gave a briefing today to explain the process of the initiative. Intellectual property is often seen as both a barrier to the diffusion of health technologies and an innovation enabler.
Evaluation Starts On WHO Global Strategy For Public Health, Innovation, IPRs 29/01/2016 by Catherine Saez, Intellectual Property Watch 1 Comment This morning, World Health Organization Executive Board members took note of a report by the WHO secretariat on the evaluation of the organisation’s global strategy and plan of action on public health, innovation and intellectual property. An inception report by the evaluation team was provided to the WHO in December, which has not been shared to the member states, according to the secretariat, although its results are expected to be presented to them in March. In the meantime, key points have been provided.
WHO Discusses Polio, Hepatitis C, Vaccines, Affordability 29/01/2016 by Catherine Saez, Intellectual Property Watch 1 Comment The World Health Organization Executive Board this week noted a number of reports on communicable diseases, such as poliomyelitis, and vaccines. Developing countries underlined the affordability and accessibility of treatments. The board also agreed on the setting up of an open-ended intergovernmental meeting to come to agreement on the organisation’s governance reform.